Rebecca Spalding, Bloomberg News Biotech Reporter, discusses Amgen paying $13.4 billion for a blockbuster psoriasis drug from Celgene, which is shedding the asset in order to win antitrust regulators’ sign-off for its $74 billion merger with Bristol-Myers Squibb. Aidan Mouat, CEO at Hazel Technologies, shares the solution he’s created to combat food waste. Shawn Donnan, Bloomberg News Senior Trade Reporter, explains what White House officials have to say about President Trump’s authority to force American companies to leave China. Bloomberg Businessweek Editor Joel Weber and Bloomberg Businessweek Politics Editor Jillian Goodman break down the problem with Democratic health-care proposals. And we Drive to the Close with Hilary Kramer, President and CIO at A&G Capital. 

Hosts: Carol Massar and Jason Kelly. Producer: Paul Brennan. 

Rebecca Spalding, Bloomberg News Biotech Reporter, discusses Amgen paying $13.4 billion for a blockbuster psoriasis drug from Celgene, which is shedding the asset in order to win antitrust regulators’ sign-off for its $74 billion merger with Bristol-Myers Squibb. Aidan Mouat, CEO at Hazel Technologies, shares the solution he’s created to combat food waste. Shawn Donnan, Bloomberg News Senior Trade Reporter, explains what White House officials have to say about President Trump’s authority to force American companies to leave China. Bloomberg Businessweek Editor Joel Weber and Bloomberg Businessweek Politics Editor Jillian Goodman break down the problem with Democratic health-care proposals. And we Drive to the Close with Hilary Kramer, President and CIO at A&amp;G Capital. Hosts: Carol Massar and Jason Kelly. Producer: Paul Brennan.

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and Tim Stenovec cover the changing world of money, power and technology. You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: http://bit.ly/3vTiACF. 

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and Tim Stenovec cover the changing world of money, power and technology.&nbsp;You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET:&nbsp;<a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.&nbsp;

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

Amgen to Buy Celgene Drug for $13.4 Billion, Sustainability Chemists, Trump’s Plan to Force Companies From China

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/d8b46360-7374-48a8-89fa-ae2b0096ee96/transcript

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF

In late January, the week before Commerce Secretary Howard Lutnick announced a $1.6 billion government commitment to fund a US magnet maker, bankers at his former financial services company, now run by his sons, were busy earning fees raising $1.5 billion more for the company from private investors.

The parallel deals have been questioned by Democratic lawmakers alleging possible conflicts of interest involving Lutnick and his sons. But a more basic set of questions has dogged the project: Can USA Rare Earth Inc., the company getting these public and private funds, actually produce the critical minerals and magnets the government needs to break China’s chokehold on global supplies?

For a closer look, we speak with Joe Deaux, Bloomberg News Senior Reporter for Corporate & Economic Statecraft.

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF
In late January, the week before Commerce Secretary Howard Lutnick announced a $1.6 billion government commitment to fund a US magnet maker, bankers at his former financial services company, now run by his sons, were busy earning fees raising $1.5 billion more for the company from private investors.
The parallel deals have been questioned by Democratic lawmakers alleging possible conflicts of interest involving Lutnick and his sons. But a more basic set of questions has dogged the project: Can USA Rare Earth Inc., the company getting these public and private funds, actually produce the critical minerals and magnets the government needs to break China&rsquo;s chokehold on global supplies?
For a closer look, we speak with Joe Deaux, Bloomberg News Senior Reporter for Corporate &amp; Economic Statecraft.

The Tiny Magnet Maker That Attracted $1.6 Billion From Lutnick

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/f583f701-aac0-4c60-8911-b4d0016a6ff0/transcript

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF

President Donald Trump said he would meet again with Chinese leader Xi Jinping in November, following what he said was a successful summit in Washington that was seemingly light on concrete policy outcomes. Meanwhile, oil prices declined on tentative signs that talks between the US and Iran to reopen the world’s most important energy shipping route were progressing. 

On today's episode:

- Jennifer Welch, Chief Geoeconomics Analyst for Bloomberg Economics
- Mekala Krishnan, Partner at the McKinsey Global Institute
- Carolyn Rodrigues Birkett, Permanent Representative of Guyana to the UN
- Rudina Seseri, Founder & Managing Partner at Glasswing Ventures

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF
President Donald Trump said he would meet again with Chinese leader Xi Jinping in November, following what he said was a successful summit in Washington that was seemingly light on concrete policy outcomes. Meanwhile, oil prices declined on tentative signs that talks between the US and Iran to reopen the world&rsquo;s most important energy shipping route were progressing.&nbsp;
On today's episode:
- Jennifer Welch, Chief Geoeconomics Analyst for Bloomberg Economics - Mekala Krishnan, Partner at the McKinsey Global Institute - Carolyn Rodrigues Birkett, Permanent Representative of Guyana to the UN - Rudina Seseri, Founder &amp; Managing Partner at Glasswing Ventures

Trump Says He’ll Meet Xi Twice More This Year

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/13a78187-adbc-4a22-bda4-b4d10000b388/transcript

Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek Daily."
Hosted by Carol Massar and Tim Stenovec

Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 121, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio.

You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News.
Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW

Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek Daily." Hosted by Carol Massar and Tim Stenovec Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 121, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio. You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News. Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW

Bloomberg Businessweek Weekend - September 25th, 2026

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/989deae2-9ee3-432b-a30e-b4d000ec00a2/transcript

Amgen to Buy Celgene Drug for $13.4 Billion, Sustainability Chemists, Trump’s Plan to Force Companies From China

In 1 playlist(s)

Bloomberg Businessweek

Social links

Follow podcast

Recent clips